Financial Updates – Page 3 – Financial Updates

Thoma Bravo Tops GrowthCap’s 2025 PE Rankings: Why Specialization Wins Amid Market Headwinds

GrowthCap’s 2025 Top Private Equity Firms lis...

Thoma Bravo tops the rankings, reflecting its...

Specialist and mid-market managers such as Ch...

The rankings underscore how LPs and managemen...

Top Indian-Origin U.S. Billionaires 2025: Who Leads & Where Their Wealth Grows

Americas FYI Venture Capital

Jay Chaudhry tops Indian-origin U.S. billiona...

India now leads all countries as the top orig...

Most wealth is concentrated in cybersecurity,...

Star tech CEOs such as Sundar Pichai and Saty...

US M&A Sees Big-Deal Value Surge in 2025 — But Volume & Risks Still Block Growth

Americas M&A Financial Services

U.S. M&A deal values have been volatile since...

Overall 2025 U.S. deal value is about 36% hig...

Deal volumes are growing more slowly than val...

Looking ahead to 2026, modest further volume ...

North America Staffing M&A Trends 2024: Deal Count Down, Healthcare & Place-Search Grow

Americas M&A Business Services

North American staffing M&A fell to 93 deals ...

Healthcare staffing and place & search were t...

Valuation multiples stayed broadly stable acr...

Q1 2025 deal volume is about 25% higher than ...

How the UP-NS Railroad Merger Could Reshape U.S. Freight Rail

Americas M&A Transportation & Logistics

Union Pacific is pursuing an $85 billion acqu...

UP projects about $2 billion in new revenue, ...

Labor unions, shippers, state attorneys gener...

The STB review—likely lasting up to two years...

How the 2025 U.S. Government Shutdown Is Delaying IPOs and Halting SEC Review

Americas Markets Financial Services

The October 1, 2025 U.S. government shutdown ...

The SEC issued October 9 guidance allowing is...

Few issuers have used this workaround due to ...

The disruption is raising capital costs, unde...

Medline IPO Rockets to ~$40, Raising $6.26B: Valuation Hits $50–$55B

Americas Markets Healthcare

Medline’s IPO raised about $6.3 billion at $2...

The company will use most proceeds to pay dow...

Strong first-day trading and rich valuation m...

The deal’s scale and PE backing could reopen ...

Europe’s M&A Surge: How Volume, Value & Sector Shifts Are Redefining Deals

Europe M&A Private Equity

European M&A deal volumes peaked in 2021 afte...

Europe’s largest-ever M&A transaction remains...

Recent European M&A is concentrated in energy...

Financial services M&A in Europe has weakened...

Biotech M&A Surges: AI, Oncology & Rare Diseases Drive Pharma Deals at JPM

Americas M&A Technology

Biopharma heads into the J.P. Morgan Healthca...

Recent headline deals by J&J, Eli Lilly, and ...

Expected 2025–2026 deal momentum is driven by...

Risks include smaller deal sizes, persistent ...

What IASIS Healthcare’s IPO Withdrawal Reveals About Hospital Finance Challenges

Americas M&A Healthcare Services

IASIS Healthcare, a private equity-backed hos...

The company owned 15 acute care hospitals, on...

IASIS withdrew its roughly US$300 million IPO...

In 2017, Steward Health Care acquired IASIS’s...